2013
DOI: 10.5935/abc.2013s005
|View full text |Cite
|
Sign up to set email alerts
|

I Diretriz Brasileira de Cardio-Oncologia Pediátrica da Sociedade Brasileira de Cardiologia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
8
0
8

Year Published

2014
2014
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(16 citation statements)
references
References 0 publications
0
8
0
8
Order By: Relevance
“…It is well known that the inclusion of fish in the diet while excluding red meat, is capable of promoting benefits to human health, especially because fish is lean meat. However, the results of studies that try to point out improvements achieved by the increase in fish consumption and the attempt to correlate this consumption with the increase in omega-3 intake are still inconclusive [ 46 ].…”
Section: Discussionmentioning
confidence: 99%
“…It is well known that the inclusion of fish in the diet while excluding red meat, is capable of promoting benefits to human health, especially because fish is lean meat. However, the results of studies that try to point out improvements achieved by the increase in fish consumption and the attempt to correlate this consumption with the increase in omega-3 intake are still inconclusive [ 46 ].…”
Section: Discussionmentioning
confidence: 99%
“…Os fatores de risco mais expressivos são a hipertensão arterial sistêmica, diabetes, tabagismo, sedentarismo, obesidade e consumo excessivo de álcool, todos ambiguamente responsáveis pela maior incidência de doenças cardiovasculares e câncer na população geral, em especial pulmão, mama, próstata e cólon 11,12 . O conhecimento e a importância da cardio-oncologia atravessou fronteiras e levantou a necessidade de maior orientação das instituições atuantes no Brasil, quando, em 2011, a Sociedade Brasileira de Cardiologia (SBC) publicou a 1 a Diretriz Brasileira de Cardio-Oncologia, em adultos e, em seguida, em 2013, a 1 a Diretriz Brasileira de Cardio--Oncologia Pediátrica, ambas enfatizando a importância dessa área inovadora na prática diária, diante do crescente número de pacientes atendidos em nosso país em todas as faixas etárias 13,14 .…”
unclassified
“…In this context, cardiotoxicity is defined as the effects of external agents (chemical or physical) that negatively interfere with the heart, causing structural, electrical, and functional changes to the myocardium. 11 Cancer survivors with some evidence of cardiotoxicity present a mortality rate that is on average eight times higher than that of the general population. The main symptoms include: heart failure (15 times higher); myocardial ischemia (ten times higher); central thromboembolic events such as cerebrovascular accident (nine times higher) and peripheral events such as deep venous thrombosis and pulmonary thromboembolism (4 to 6 times higher).…”
Section: Introductionmentioning
confidence: 99%
“…7,18,19 Cardiotoxicity related to cancer treatment may become manifest at any time, with reports of it occurring within 45 years or more after the end of treatment. 11,20,21 Theoretically, any chemotherapy has the potential to cause toxicity. 7 The main chemotherapeutic agents that present cardiotoxicity include anthracyclines (such as doxorubicin, epirubicin, and idarubicin), alkylating agents (cyclophosphamide and ifosfamide), antimicrotubule agents (such as paclitaxel and docetaxel), monoclonal antibodies (such as trastuzumab, bevacizumab), and tyrosine kinase inhibitor (such as sunitinib).…”
Section: Introductionmentioning
confidence: 99%